William Blair & Company
TENX icon

William Blair & Company’s Tenax Therapeutics TENX Stock Holding History

William Blair & Company’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed -$19K – 1929
2021
Q1 		$19K Hold
6
– – ﹤0.01% 1753
2020
Q4 		$19K Hold
6
– – ﹤0.01% 1708
2020
Q3 		$15K Hold
6
– – ﹤0.01% 1604
2020
Q2 		$9K Buy
+6
New +$8.82K ﹤0.01% 1600

Other funds holding TENX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair & Company's TENX Position: Q2 2021 in Review

William Blair & Company sold out of Tenax Therapeutics (TENX) in Q2 2021, closing a stake of 6 shares — an estimated $19K sold.

William Blair & Company first reported a position in TENX in Q2 2020 and held it in 4 quarters. The position peaked at $19K in Q1 2021. 15 funds tracked by Wall St. Rank hold TENX as of Q2 2021.

  • William Blair & Company reported no remaining Tenax Therapeutics position as of Q2 2021 after selling out during the quarter.
  • William Blair & Company sold 6 Tenax Therapeutics shares in Q2 2021, an estimated $19K.
  • William Blair & Company first reported a position in Tenax Therapeutics in Q2 2020 and held it in 4 quarters.
  • William Blair & Company's Tenax Therapeutics position peaked at $19K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2021.

Based on William Blair & Company's 13F filing for Q2 2021, filed 12 Aug 2021.